Weather Advisory: Temporary Door Closure

Due to extreme cold, access through the Moakley Building's entrance off Boston Medical Center Place will be temporarily closed from 5 p.m. Friday, Jan. 30, through 7 a.m. Monday, Feb. 2.

All patients and visitors should use the main entrance for the Menino and Yawkey Buildings during this time. The hospital remains open and operating as normal.

We appreciate your patience as we take these precautions during severe winter weather.

Language

Sickle Cell Disease Program

Treatments and Services

BMC offers all treatments and therapies for sickle cell disease, including:

  • Gene therapies: Boston Medical Center offers both FDA-approved transformative gene therapies, Casgevy and Lyfgenia, to eligible adults with sickle cell disease.
  • Hydroxyurea
  • L-glutamine
  • Voxelotor
  • Crizanlizumab
  • Blood transfusions
  • Pain medications